O. Yu. Druzhilova

O. Yu. Druzhilova

Auto-generated profile, based on publicly available information

O. Yu. Druzhilova

Petrozavodsk State University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2018 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
MDM. A. Druzhilov
M. A. Druzhilov
TKTatiana Kuznetsova
Tatiana Kuznetsova
ОDО. Yu. Druzhilova
О. Yu. Druzhilova
ТКТ. Ю. Кузнецова
Т. Ю. Кузнецова
Taken the continuous increase of obesity prevalence, most countries in the world deal with an epidemy, one of the main healthcare concerns. In the structure of nosology associated with overweight and obesity, cardiovascular is leading. Also, in the recent trials and meta analyses there is negative correlation found for body mass index and clinical outcomes characterizing better survival and lower events rate in those with higher BMI, as less chronic diseases. Such facts facilitated a number of discussions on the predictive value of overweight and obesity and consideration whether to correct those in cardiovascular patients as secondary prevention. Current article is focused on the main causes for an “inverse” cardiovascular epidemiology in overweight and obesity.

9 May 2023 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
MDM. A. Druzhilov
M. A. Druzhilov
TKTatiana Kuznetsova
Tatiana Kuznetsova
ODO. Yu. Druzhilova
O. Yu. Druzhilova
UAU. D. Arustamova
U. D. Arustamova
DGD. V. Gavrilov
D. V. Gavrilov
ТКТ. Ю. Кузнецова
Т. Ю. Кузнецова
Aim. To compare clinical characteristics of patients with atrial fibrillation (AF) depending on renal filtration function based on a retrospective analysis of data in individual subjects of the Russian Federation (RF).Material and methods. The information was taken from the Webiomed predictive analytics platform, including 80775 patients with AF (men, 42,5%, mean age, 70,0±14,3 years) who underwent outpatient and/or inpatient treatment in medical organizations in 6 Russian subjects in 2016-2019 with data on blood creatinine levels. For comparative analysis, the ranges of estimated glomerular filtration rate (eGFR) were selected: ≥60 ml/min/1,73 m2, 30–59 ml/min/1,73 m2, and <30 ml/min/1,73 m2.Results. The analysis showed that 45128 (55,9%) patients were characterized by eGFR <60 ml/min/1,73 m2, of which in 35212 (78%) patients eGFR was in the range of 30-59 ml/min/1,73 m2, in 9916 (22%) — <30 ml/min/1,73 m2. Patients with eGFR <60 ml/min/1,73 m2 compared with those with eGFR ≥60 ml/min/1,73 m2 were older (75,4±10,9 vs 63,0±15,2 years, p<0,001), had higher incidence of ischemic stroke (IS) (10,9 vs 6,5%, p<0,001), myocardial infarction (MI) (11,5 vs 7,7%, p<0,001) and intracranial hemorrhage (ICH) (1,0 vs 0,7%, p<0,01), as well as higher rate of anticoagulant therapy (ACT) (47,0 vs 33,2%, p<0,001). Men and women with eGFR of 30-59 and <30 ml/min/1,73 m2 in the age ranges ≤64 years and 65-74 years had a higher incidence of IS and MI compared with patients with eGFR ≥60 ml/min/173 m2. The frequency of ICH on warfarin compared with direct oral anticoagulants was significantly higher in the subgroup with eGFR of 30-59 ml/min/1,73 m2 (1,1 vs 0,7%, p<0,01).Conclusion. Patients with AF and eGFR <60 ml/min/1,73 m2 are charac­terized by greater comorbidity, a higher incidence of IS, MI and ICH compared with patients with AF and eGFR ≥60 ml/min/1,73 m2, while ACT prescription rate as of 2016-2019 in some Russian subjects was unsatisfactory. This emphasizes the need to optimize risk stratification, ACT and algorithms for the prevention of athero­thrombotic events, as well as the development of nephro­protective strategies to reduce the rate of progression of renal dys­function in this cohort of patients.

2 June 2018 in Russian Journal of Cardiology
Verified
Journal Article
Open access
ODO. Yu. Druzhilova
O. Yu. Druzhilova
MDM. A. Druzhilov
M. A. Druzhilov
TKTatiana Kuznetsova
Tatiana Kuznetsova
ТКТ. Ю. Кузнецова
Т. Ю. Кузнецова
ПРОГНОСТИЧЕСКОЕ ЗНАЧЕНИЕ ПОКАЗАТЕЛЕЙ АРТЕРИАЛЬНОЙ ЖЕСТКОСТИ ПРИ ОЦЕНКЕ КАРДИОМЕТАБОЛИЧЕСКОГО РИСКА У ПАЦИЕНТОВ С ОЖИРЕНИЕМ

10 June 2024 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
MDM. A. Druzhilov
M. A. Druzhilov
ODO. Yu. Druzhilova
O. Yu. Druzhilova
ZIZ. A. Ilchenko
Z. A. Ilchenko
PCP. I. Chalaya
P. I. Chalaya
TKTatiana Kuznetsova
Tatiana Kuznetsova
ТКТ. Ю. Кузнецова
Т. Ю. Кузнецова
Aim. This retrospective analysis of anticoagulant therapy prescription rate in patients with atrial fibrillation (AF) aged ³18 years in certain Russian regions in 20162019 using artificial intelligence technologies.Material and methods. Anonymized data of patients with AF aged ³18 years (n=144431; men, 42,0%; mean age, 68,9±15,7 years; mean CHA2DS2-VASc score, 3,2±1,8) were extracted from the Webiomed predictive analytics service using continuous sampling from electronic health records in medical facilities of 6 Russian constituent entities (Republic of Bashkortostan, Republic of Buryatia, Republic of Karelia, Republic of Sakha (Yakutia), Perm Krai, Yamalo-Nenets Autonomous Okrug) for 2016-2019 using artificial intelligence technologies. Results. Anticoagulant therapy prescription rate in the total sample was 29,7%. Patients with AF and a high thromboembolism risk received anticoagulants in 34,8% of cases. Anticoagulant therapy was prescribed significantly less frequently to women with AF compared to men. In the subgroup of individuals aged under 75 years, anticoagulant therapy prescription rate with a high thromboembolism risk exceeded the same indicator in the subgroup of individuals aged ³75 years as follows: 41,2% vs 29,6% (p<0,001). In patients with AF under 75 years and a high thromboembolism risk, anticoagulant therapy prescription rate significantly gained with an increase in the number of points on the CHA2DS2-VASc scale in the range from 33,2% to 61,9%, in patients aged ³75 years — in the range from 13,0% to 55,5%. We revealed that 23317 (16,1%) patients were prescribed direct oral anticoagulants, of which 9,655 (41,4%) patients initially received warfarin.Conclusion. The study results indicate an unsatisfactory anticoagulant therapy prescription rate in patients with AF and a high thromboembolism risk in certain Russian regions in 2016-2019. Despite its growth with a CHA2DS2-VASc score increase in the high-risk range, it did not comply with current clinical guidelines This specifies the need for stricter control over the implementation of treatment and diagnostic algorithms and local protocols for managing these patients.

8 August 2025 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
MDM. A. Druzhilov
M. A. Druzhilov
ODO. Yu. Druzhilova
O. Yu. Druzhilova
TKTatiana Kuznetsova
Tatiana Kuznetsova
DGD. V. Gavrilov
D. V. Gavrilov
ТКТ. Ю. Кузнецова
Т. Ю. Кузнецова
Aim. To conduct a retrospective analysis of anticoagulation prescription rate, including direct oral anticoagulants (DOAC), to patients with atrial fibrillation and high risk of thromboembolic events (TEEs) in certain Russian regions as of December 31, 2023.Material and methods. The analyzed group of patients was formed based on the information contained in the Webiomed predictive analytics platform (OOO K-Sky, Petrozavodsk, Russia). The information was presented as the extracted depersonalized anonymized data from the electronic health records of patients aged ≥18 years, attached to medical facilities of 17 Russian subjects (n=107561, men 37,8%, mean age 74,5±8,5 years, mean CHA2DS2-VASc score of 3,6±1,2) extracted by the continuous sampling method.Results. Anticoagulation prescription rate in the group as a whole was 53,7%, while the DOAC share in its structure was 87,0%. Acetylsalicylic acid for TEE prevention was prescribed in 10,6% of cases. With an increase of non-gender-specific CHA2DS2-VASc score, the percentage of people receiving anticoagulation increased — from 49,7% with 2 points to 73,9% with 8 points. Anticoagulation was prescribed to patients aged ≥75 years significantly less often (49,1%, p<0,001). Regardless of age and type of arrhythmia, anticoagulants were prescribed to men significantly more often than to women.Conclusion. The results of retrospective analysis indicate improvement in anticoagulation prescription rate for atrial fibrillation and a high risk of TEEs in certain Russian regions. Compared to a similar study for 2016-2019, in 2023 this indicator increased from 34,8% to 53,7%. The share of DOACs in anticoagulant therapy structure also increased significantly — from 52,0% to 87,0%. At the same time, oral anticoagulation rate in this cohort of patients still does not meet the requirements of current clinical guidelines.

10 December 2019 in "Arterial’naya Gipertenziya" ("Arterial Hypertension")
Verified
Journal Article
Open access
PDF file
MDM. A. Druzhilov
M. A. Druzhilov
ODO. Y. Druzhilova
O. Y. Druzhilova
TKTatiana Kuznetsova
Tatiana Kuznetsova
ТКТ. Ю. Кузнецова
Т. Ю. Кузнецова
Objective. The aim was to assess the role of the aortic pulse wave velocity (PWVao) as additional predictor of hypertension (HTN) development in men with obesity.Design and methods. 526 men without HTN (according to ambulatory blood pressure monitoring (ABPM) without therapy) (age 45,1 ± 5,0 years) with abdominal obesity (waist circumference > 94 cm) and SCORE < 5 %, without cardiovascular diseases and diabetes mellitus were examined. The diagnostic tests included the lipid and glucose profiles, creatinine, albuminuria evaluation, echocardiography, carotid ultrasound, bifunctional ABPM (portable recorder BPLab®) with average daily PWVao assessment. Patients with subclinical carotid atherosclerosis (n = 98) were excluded from the follow-up. Follow-up examination including ABPM was conducted on average after 46,3 ± 5,1 months.Results. Data of 406 subjects were available for analysis. HTN defined as average daily BP ≥ 130/80 mm Hg was found in 157 patients (38,7 %). The mathematical model included the following parameters: age, body mass index, mean daily systolic BP and mean daily PWVao. Among these predictors a PWVao was characterized by the highest standardized regression coefficient (0,461, p < 0,001). The area under the ROC-curve was 0,945 (95 % confidence interval 0,920–0,971, р < 0,001). At the selected cut-off point of PWVao 7,7 m/s the sensitivity and specificity of the model were 85,4 % and 96,8 %, respectively.Conclusions. The mathematical model for assessing the probability of HTN development in patients with obesity which includes the PWVao is characterized by a high overall percentage of correct classifications with comparability with actual data. Bifunctional ABPM with the PWVao evaluation in patients with obesity is the preferred method for additional prognostic assessment.